miltefosine has been researched along with Sepsis in 2 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Miltefosine was orally administered at doses of 15 and 30 mg/kg/day after, at the time of, and before bacterial challenge for 3-5 days." | 1.35 | In vitro and in vivo activity of miltefosine against penicillin-sensitive and -resistant Streptococcus pneumoniae strains. ( Del Prado, G; Gracia, M; Huelves, L; Ponte, C; Rodríguez-Cerrato, V, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huelves, L | 1 |
| Del Prado, G | 1 |
| Gracia, M | 1 |
| Rodríguez-Cerrato, V | 1 |
| Ponte, C | 1 |
| Ferguson, LM | 1 |
| Dreisbach, AW | 1 |
| Csongrádi, E | 1 |
| Juncos, LA | 1 |
| Fulop, T | 1 |
2 other studies available for miltefosine and Sepsis
| Article | Year |
|---|---|
In vitro and in vivo activity of miltefosine against penicillin-sensitive and -resistant Streptococcus pneumoniae strains.
Topics: Animals; Anti-Bacterial Agents; Bacteriological Techniques; Dose-Response Relationship, Drug; Mice; | 2008 |
Recurring extracorporeal circuit clotting during continuous renal replacement therapy in fungal sepsis: successful treatment with argatroban.
Topics: Antifungal Agents; Antithrombins; Arginine; Blood Coagulation; Coronary Artery Bypass; Humans; Male; | 2013 |